Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the 'real world'. One-year results from a nationwide French survey

  • Danchin N
  • Vaur L
  • Genes N
 et al. 
  • 9

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Background-Recent randomized trials comparing primary coronary angioplasty and intravenous thrombolysis at the acute stage of myocardial infarction have shown a limited but definite advantage for primary angioplasty. The aim of this study was to document 1-year outcome in patients receiving either thrombolysis or primary angioplasty for acute myocardial infarction in the 'real world.' Methods and Results We used a nationwide prospective registry of all patients admitted for acute myocardial infarction in French intensive care units in November 1995. Of the 721 patients who received reperfusion therapy, 152 were treated with primary angioplasty and 569 received intravenous thrombolysis. The two groups were remarkably similar with respect to all baseline descriptors, except that a higher proportion of patients in the angioplasty group had a history of cerebrovascular accident (10% versus 2%, P

Author-supplied keywords

  • Angioplasty
  • France
  • Myocardial infarction
  • Thrombolysis
  • acetylsalicylic acid/dt [Drug Therapy]
  • acute heart infarction/dt [Drug Therapy]
  • acute heart infarction/th [Therapy]
  • adult
  • age
  • aged
  • antiarrhythmic agent
  • antilipemic agent
  • antithrombocytic agent/dt [Drug Therapy]
  • article
  • beta adrenergic receptor blocking agent/dt [Drug T
  • calcium antagonist/dt [Drug Therapy]
  • cerebrovascular accident
  • clinical trial
  • controlled clinical trial
  • controlled study
  • digitalis/dt [Drug Therapy]
  • dipeptidyl carboxypeptidase inhibitor/dt [Drug The
  • diuretic agent/dt [Drug Therapy]
  • female
  • fibrinolytic agent/ad [Drug Administration]
  • fibrinolytic agent/ct [Clinical Trial]
  • fibrinolytic agent/dt [Drug Therapy]
  • fibrinolytic therapy
  • gender
  • heart failure
  • heart muscle reperfusion
  • human
  • intensive care unit
  • intravenous drug administration
  • major clinical study
  • male
  • mortality
  • priority journal
  • prognosis
  • risk factor
  • survival rate
  • transluminal coronary angioplasty

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • N Danchin

  • L Vaur

  • N Genes

  • S Etienne

  • M Angioi

  • J Ferrieres

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free